nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—Enzalutamide—ALB—metabolic syndrome X	0.0114	1	CrCbGaD
Nilutamide—AR—penis—metabolic syndrome X	0.00936	0.407	CbGeAlD
Nilutamide—CYP2C9—Metapathway biotransformation—FMO3—metabolic syndrome X	0.0038	0.00401	CbGpPWpGaD
Nilutamide—CYP2C19—Metapathway biotransformation—EPHX2—metabolic syndrome X	0.00371	0.00392	CbGpPWpGaD
Nilutamide—CYP2C8—Arachidonic acid metabolism—PLA2G4A—metabolic syndrome X	0.00361	0.00381	CbGpPWpGaD
Nilutamide—CYP2C9—Arachidonic acid metabolism—GGT1—metabolic syndrome X	0.00356	0.00376	CbGpPWpGaD
Nilutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.00347	0.00366	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—EPHX2—metabolic syndrome X	0.00339	0.00358	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—metabolic syndrome X	0.00338	0.00358	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—SIRT1—metabolic syndrome X	0.00332	0.00351	CbGpPWpGaD
Nilutamide—CYP2C19—Arachidonic acid metabolism—PLA2G4A—metabolic syndrome X	0.00322	0.0034	CbGpPWpGaD
Nilutamide—AR—Nongenotropic Androgen signaling—AKT1—metabolic syndrome X	0.0032	0.00338	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—NR1I3—metabolic syndrome X	0.00312	0.0033	CbGpPWpGaD
Nilutamide—CYP2C9—Arachidonic acid metabolism—PLA2G4A—metabolic syndrome X	0.00294	0.0031	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—NR3C1—metabolic syndrome X	0.00287	0.00303	CbGpPWpGaD
Nilutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.00286	0.00303	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—NR1I2—metabolic syndrome X	0.00285	0.00302	CbGpPWpGaD
Nilutamide—AR—Gene Expression—EDC4—metabolic syndrome X	0.00281	0.00297	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—SIRT1—metabolic syndrome X	0.00275	0.00291	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PLA2G4A—metabolic syndrome X	0.00264	0.00279	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—IRS1—metabolic syndrome X	0.00234	0.00247	CbGpPWpGaD
Nilutamide—POR—adipose tissue—metabolic syndrome X	0.00225	0.0978	CbGeAlD
Nilutamide—AR—Gene Expression—NR1H3—metabolic syndrome X	0.00205	0.00217	CbGpPWpGaD
Nilutamide—CYP2C8—Arachidonic acid metabolism—PTGS2—metabolic syndrome X	0.00203	0.00215	CbGpPWpGaD
Nilutamide—AR—Coregulation of Androgen receptor activity—AKT1—metabolic syndrome X	0.00186	0.00197	CbGpPWpGaD
Nilutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—metabolic syndrome X	0.00182	0.00192	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	0.00179	0.0019	CbGpPWpGaD
Nilutamide—CYP2C9—Arachidonic acid metabolism—PTGS2—metabolic syndrome X	0.00166	0.00175	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—GGT1—metabolic syndrome X	0.00163	0.00172	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	0.00162	0.00171	CbGpPWpGaD
Nilutamide—POR—liver—metabolic syndrome X	0.00158	0.0686	CbGeAlD
Nilutamide—AR—cardiovascular system—metabolic syndrome X	0.00151	0.0655	CbGeAlD
Nilutamide—AR—Gene Expression—NR1I3—metabolic syndrome X	0.0015	0.00159	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	0.00149	0.00157	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—metabolic syndrome X	0.00149	0.00157	CbGpPWpGaD
Nilutamide—AR—kidney—metabolic syndrome X	0.00147	0.0641	CbGeAlD
Nilutamide—CYP2C19—Biological oxidations—GGT1—metabolic syndrome X	0.00145	0.00153	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	0.00145	0.00153	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—AKT1—metabolic syndrome X	0.00138	0.00146	CbGpPWpGaD
Nilutamide—AR—Gene Expression—NR1I2—metabolic syndrome X	0.00137	0.00145	CbGpPWpGaD
Nilutamide—AR—adipose tissue—metabolic syndrome X	0.00133	0.0578	CbGeAlD
Nilutamide—CYP2C9—Biological oxidations—GGT1—metabolic syndrome X	0.00132	0.0014	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	0.00132	0.00139	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	0.00129	0.00137	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	0.00123	0.0013	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—NR3C1—metabolic syndrome X	0.00121	0.00128	CbGpPWpGaD
Nilutamide—CYP2C8—kidney—metabolic syndrome X	0.00119	0.0518	CbGeAlD
Nilutamide—AR—SIDS Susceptibility Pathways—TNF—metabolic syndrome X	0.00118	0.00125	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	0.00116	0.00122	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—PPARA—metabolic syndrome X	0.00114	0.0012	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	0.0011	0.00116	CbGpPWpGaD
Nilutamide—CYP2C9—cardiovascular system—metabolic syndrome X	0.00108	0.0471	CbGeAlD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	0.00108	0.00114	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	0.00107	0.00113	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	0.00105	0.00111	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	0.00104	0.0011	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	0.00101	0.00107	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	0.001	0.00106	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	0.001	0.00106	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	0.000999	0.00106	CbGpPWpGaD
Nilutamide—Influenza—Metformin—metabolic syndrome X	0.000978	0.0512	CcSEcCtD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	0.000953	0.00101	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—IL6—metabolic syndrome X	0.000953	0.00101	CbGpPWpGaD
Nilutamide—Angina pectoris—Metformin—metabolic syndrome X	0.000952	0.0499	CcSEcCtD
Nilutamide—AR—Generic Transcription Pathway—PPARG—metabolic syndrome X	0.000939	0.000992	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	0.000932	0.000984	CbGpPWpGaD
Nilutamide—AR—liver—metabolic syndrome X	0.000931	0.0405	CbGeAlD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	0.00093	0.000983	CbGpPWpGaD
Nilutamide—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.000909	0.0476	CcSEcCtD
Nilutamide—AR—Integrated Breast Cancer Pathway—AKT1—metabolic syndrome X	0.000902	0.000953	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	0.000902	0.000953	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	0.000893	0.000944	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	0.000869	0.000918	CbGpPWpGaD
Nilutamide—CYP2C19—liver—metabolic syndrome X	0.000863	0.0375	CbGeAlD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	0.000849	0.000897	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—SERPINE1—metabolic syndrome X	0.000846	0.000894	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	0.00083	0.000877	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	0.000829	0.000876	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	0.000824	0.000871	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	0.000823	0.000869	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	0.000814	0.00086	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—FMO3—metabolic syndrome X	0.000809	0.000855	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	0.0008	0.000845	CbGpPWpGaD
Nilutamide—Rhinitis—Metformin—metabolic syndrome X	0.000784	0.0411	CcSEcCtD
Nilutamide—Hypoaesthesia—Metformin—metabolic syndrome X	0.000779	0.0408	CcSEcCtD
Nilutamide—Oedema peripheral—Metformin—metabolic syndrome X	0.000771	0.0404	CcSEcCtD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	0.000766	0.000809	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	0.000757	0.0008	CbGpPWpGaD
Nilutamide—CYP2C8—liver—metabolic syndrome X	0.000753	0.0328	CbGeAlD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	0.000748	0.00079	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	0.000744	0.000786	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	0.00074	0.000782	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	0.000736	0.000777	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	0.000723	0.000764	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—FMO3—metabolic syndrome X	0.000722	0.000763	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—MLXIPL—metabolic syndrome X	0.000721	0.000762	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—EPHX2—metabolic syndrome X	0.000721	0.000762	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	0.000714	0.000754	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	0.000684	0.000722	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—G6PC2—metabolic syndrome X	0.000678	0.000717	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	0.000675	0.000713	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	0.000671	0.000709	CbGpPWpGaD
Nilutamide—CYP2C9—liver—metabolic syndrome X	0.000669	0.0291	CbGeAlD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	0.000664	0.000701	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—FMO3—metabolic syndrome X	0.000659	0.000696	CbGpPWpGaD
Nilutamide—AR—Gene Expression—SIRT1—metabolic syndrome X	0.000658	0.000695	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	0.000651	0.000688	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	0.000646	0.000682	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	0.000645	0.000681	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—EPHX2—metabolic syndrome X	0.000644	0.00068	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—MLXIPL—metabolic syndrome X	0.000644	0.00068	CbGpPWpGaD
Nilutamide—Ill-defined disorder—Metformin—metabolic syndrome X	0.000632	0.0331	CcSEcCtD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	0.000625	0.00066	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	0.000624	0.000659	CbGpPWpGaD
Nilutamide—Malaise—Metformin—metabolic syndrome X	0.000614	0.0322	CcSEcCtD
Nilutamide—Syncope—Metformin—metabolic syndrome X	0.000611	0.032	CcSEcCtD
Nilutamide—CYP2C19—Metabolism—G6PC2—metabolic syndrome X	0.000605	0.00064	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	0.000605	0.000639	CbGpPWpGaD
Nilutamide—Loss of consciousness—Metformin—metabolic syndrome X	0.000599	0.0314	CcSEcCtD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	0.000589	0.000622	CbGpPWpGaD
Nilutamide—Hypertension—Metformin—metabolic syndrome X	0.000588	0.0308	CcSEcCtD
Nilutamide—CYP2C9—Metabolism—EPHX2—metabolic syndrome X	0.000587	0.00062	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—MLXIPL—metabolic syndrome X	0.000587	0.00062	CbGpPWpGaD
Nilutamide—AR—Gene Expression—NR3C1—metabolic syndrome X	0.000584	0.000617	CbGpPWpGaD
Nilutamide—Chest pain—Metformin—metabolic syndrome X	0.00058	0.0304	CcSEcCtD
Nilutamide—CYP2C8—Metabolism—FABP4—metabolic syndrome X	0.000577	0.000609	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	0.000576	0.000608	CbGpPWpGaD
Nilutamide—Discomfort—Metformin—metabolic syndrome X	0.000573	0.03	CcSEcCtD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	0.000557	0.000589	CbGpPWpGaD
Nilutamide—Oedema—Metformin—metabolic syndrome X	0.000556	0.0291	CcSEcCtD
Nilutamide—CYP2C9—Metabolism—G6PC2—metabolic syndrome X	0.000552	0.000583	CbGpPWpGaD
Nilutamide—AR—Gene Expression—PPARA—metabolic syndrome X	0.000547	0.000578	CbGpPWpGaD
Nilutamide—Shock—Metformin—metabolic syndrome X	0.000547	0.0287	CcSEcCtD
Nilutamide—CYP2C8—Metabolism—HSD11B1—metabolic syndrome X	0.000547	0.000578	CbGpPWpGaD
Nilutamide—Hyperhidrosis—Metformin—metabolic syndrome X	0.000537	0.0282	CcSEcCtD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	0.00053	0.00056	CbGpPWpGaD
Nilutamide—Anorexia—Metformin—metabolic syndrome X	0.00053	0.0278	CcSEcCtD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	0.000525	0.000554	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	0.000516	0.000545	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—FABP4—metabolic syndrome X	0.000515	0.000544	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	0.000508	0.000537	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	0.000506	0.000535	CbGpPWpGaD
Nilutamide—Paraesthesia—Metformin—metabolic syndrome X	0.000499	0.0262	CcSEcCtD
Nilutamide—Dyspnoea—Metformin—metabolic syndrome X	0.000496	0.026	CcSEcCtD
Nilutamide—Dyspepsia—Metformin—metabolic syndrome X	0.000489	0.0256	CcSEcCtD
Nilutamide—CYP2C19—Metabolism—HSD11B1—metabolic syndrome X	0.000488	0.000516	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—G6PD—metabolic syndrome X	0.000487	0.000515	CbGpPWpGaD
Nilutamide—Decreased appetite—Metformin—metabolic syndrome X	0.000483	0.0253	CcSEcCtD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	0.000481	0.000508	CbGpPWpGaD
Nilutamide—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00048	0.0251	CcSEcCtD
Nilutamide—CYP2C8—Metabolism—HDAC3—metabolic syndrome X	0.000476	0.000502	CbGpPWpGaD
Nilutamide—Constipation—Metformin—metabolic syndrome X	0.000475	0.0249	CcSEcCtD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	0.000473	0.0005	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—FABP4—metabolic syndrome X	0.000469	0.000496	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—LPA—metabolic syndrome X	0.000465	0.000491	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GCKR—metabolic syndrome X	0.000465	0.000491	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	0.00046	0.000486	CbGpPWpGaD
Nilutamide—Feeling abnormal—Metformin—metabolic syndrome X	0.000458	0.024	CcSEcCtD
Nilutamide—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000455	0.0238	CcSEcCtD
Nilutamide—AR—Gene Expression—PPARG—metabolic syndrome X	0.000452	0.000478	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	0.000452	0.000477	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PLA2G6—metabolic syndrome X	0.00045	0.000476	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	0.000447	0.000472	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOA5—metabolic syndrome X	0.000446	0.000471	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HSD11B1—metabolic syndrome X	0.000445	0.00047	CbGpPWpGaD
Nilutamide—Abdominal pain—Metformin—metabolic syndrome X	0.000439	0.023	CcSEcCtD
Nilutamide—CYP2C19—Metabolism—G6PD—metabolic syndrome X	0.000435	0.000459	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	0.000433	0.000457	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	0.000431	0.000456	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	0.000429	0.000453	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HDAC3—metabolic syndrome X	0.000425	0.000448	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	0.000424	0.000448	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	0.00042	0.000443	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	0.000419	0.000443	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—LPA—metabolic syndrome X	0.000415	0.000438	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GCKR—metabolic syndrome X	0.000415	0.000438	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—TRIB3—metabolic syndrome X	0.000414	0.000438	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	0.000412	0.000435	CbGpPWpGaD
Nilutamide—AR—Gene Expression—SERPINE1—metabolic syndrome X	0.000407	0.00043	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PLA2G6—metabolic syndrome X	0.000402	0.000425	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	0.000399	0.000421	CbGpPWpGaD
Nilutamide—Asthenia—Metformin—metabolic syndrome X	0.000399	0.0209	CcSEcCtD
Nilutamide—CYP2C19—Metabolism—APOA5—metabolic syndrome X	0.000398	0.00042	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—G6PD—metabolic syndrome X	0.000397	0.000419	CbGpPWpGaD
Nilutamide—Pruritus—Metformin—metabolic syndrome X	0.000393	0.0206	CcSEcCtD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	0.000391	0.000413	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HDAC3—metabolic syndrome X	0.000387	0.000409	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	0.000386	0.000408	CbGpPWpGaD
Nilutamide—Diarrhoea—Metformin—metabolic syndrome X	0.00038	0.0199	CcSEcCtD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	0.000379	0.0004	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GCKR—metabolic syndrome X	0.000378	0.0004	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—LPA—metabolic syndrome X	0.000378	0.0004	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	0.000374	0.000395	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NAMPT—metabolic syndrome X	0.000372	0.000393	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—TRIB3—metabolic syndrome X	0.00037	0.000391	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	0.000369	0.00039	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GCK—metabolic syndrome X	0.000369	0.00039	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—LIPC—metabolic syndrome X	0.000369	0.00039	CbGpPWpGaD
Nilutamide—Dizziness—Metformin—metabolic syndrome X	0.000368	0.0193	CcSEcCtD
Nilutamide—CYP2C8—Metabolism—APOC3—metabolic syndrome X	0.000367	0.000388	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PLA2G6—metabolic syndrome X	0.000366	0.000387	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	0.000364	0.000384	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOA5—metabolic syndrome X	0.000363	0.000383	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CETP—metabolic syndrome X	0.000356	0.000376	CbGpPWpGaD
Nilutamide—Vomiting—Metformin—metabolic syndrome X	0.000353	0.0185	CcSEcCtD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	0.000352	0.000372	CbGpPWpGaD
Nilutamide—Rash—Metformin—metabolic syndrome X	0.000351	0.0184	CcSEcCtD
Nilutamide—Dermatitis—Metformin—metabolic syndrome X	0.00035	0.0183	CcSEcCtD
Nilutamide—Headache—Metformin—metabolic syndrome X	0.000348	0.0182	CcSEcCtD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	0.000345	0.000365	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	0.000341	0.000361	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SCARB1—metabolic syndrome X	0.000341	0.00036	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—TRIB3—metabolic syndrome X	0.000337	0.000356	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	0.000332	0.000351	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NAMPT—metabolic syndrome X	0.000332	0.00035	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SREBF1—metabolic syndrome X	0.000331	0.00035	CbGpPWpGaD
Nilutamide—Nausea—Metformin—metabolic syndrome X	0.00033	0.0173	CcSEcCtD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	0.00033	0.000348	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—LIPC—metabolic syndrome X	0.00033	0.000348	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GCK—metabolic syndrome X	0.00033	0.000348	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOC3—metabolic syndrome X	0.000328	0.000346	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HMGCR—metabolic syndrome X	0.000322	0.00034	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GOT2—metabolic syndrome X	0.000322	0.00034	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CETP—metabolic syndrome X	0.000318	0.000336	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SCARB1—metabolic syndrome X	0.000305	0.000322	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NAMPT—metabolic syndrome X	0.000302	0.00032	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	0.000301	0.000318	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—LIPC—metabolic syndrome X	0.000301	0.000318	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GCK—metabolic syndrome X	0.000301	0.000318	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOC3—metabolic syndrome X	0.000299	0.000316	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	0.000297	0.000313	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SREBF1—metabolic syndrome X	0.000296	0.000312	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	0.000291	0.000307	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CETP—metabolic syndrome X	0.00029	0.000306	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HMGCR—metabolic syndrome X	0.000288	0.000304	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GOT2—metabolic syndrome X	0.000288	0.000304	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ABCA1—metabolic syndrome X	0.000287	0.000303	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SLC2A4—metabolic syndrome X	0.000287	0.000303	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GGT1—metabolic syndrome X	0.000278	0.000294	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GOT1—metabolic syndrome X	0.000278	0.000294	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SCARB1—metabolic syndrome X	0.000278	0.000293	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	0.00027	0.000286	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SREBF1—metabolic syndrome X	0.00027	0.000285	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HMGCR—metabolic syndrome X	0.000262	0.000277	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GOT2—metabolic syndrome X	0.000262	0.000277	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	0.000259	0.000274	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ABCA1—metabolic syndrome X	0.000256	0.000271	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SLC2A4—metabolic syndrome X	0.000256	0.000271	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GGT1—metabolic syndrome X	0.000248	0.000262	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GOT1—metabolic syndrome X	0.000248	0.000262	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	0.000237	0.00025	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOB—metabolic syndrome X	0.000236	0.000249	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ABCA1—metabolic syndrome X	0.000234	0.000247	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SLC2A4—metabolic syndrome X	0.000234	0.000247	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PLA2G4A—metabolic syndrome X	0.00023	0.000243	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GGT1—metabolic syndrome X	0.000226	0.000239	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GOT1—metabolic syndrome X	0.000226	0.000239	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—LPL—metabolic syndrome X	0.000225	0.000238	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CD36—metabolic syndrome X	0.000214	0.000226	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOB—metabolic syndrome X	0.000211	0.000223	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PLA2G4A—metabolic syndrome X	0.000205	0.000216	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—LPL—metabolic syndrome X	0.000201	0.000213	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PPARA—metabolic syndrome X	0.000199	0.00021	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—AGT—metabolic syndrome X	0.000193	0.000204	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOB—metabolic syndrome X	0.000192	0.000203	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CD36—metabolic syndrome X	0.000191	0.000202	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOE—metabolic syndrome X	0.000189	0.0002	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PLA2G4A—metabolic syndrome X	0.000187	0.000197	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOA1—metabolic syndrome X	0.000187	0.000197	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—LPL—metabolic syndrome X	0.000183	0.000194	CbGpPWpGaD
Nilutamide—AR—Gene Expression—AKT1—metabolic syndrome X	0.000179	0.000189	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PPARA—metabolic syndrome X	0.000178	0.000188	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CD36—metabolic syndrome X	0.000174	0.000184	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—AGT—metabolic syndrome X	0.000172	0.000182	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOE—metabolic syndrome X	0.000169	0.000178	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOA1—metabolic syndrome X	0.000167	0.000176	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PPARG—metabolic syndrome X	0.000165	0.000174	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPARA—metabolic syndrome X	0.000162	0.000171	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—INS—metabolic syndrome X	0.000161	0.00017	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—AGT—metabolic syndrome X	0.000157	0.000166	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOE—metabolic syndrome X	0.000154	0.000162	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOA1—metabolic syndrome X	0.000152	0.000161	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALB—metabolic syndrome X	0.000148	0.000156	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PPARG—metabolic syndrome X	0.000147	0.000155	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—INS—metabolic syndrome X	0.000144	0.000152	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NOS3—metabolic syndrome X	0.000142	0.00015	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPARG—metabolic syndrome X	0.000134	0.000141	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALB—metabolic syndrome X	0.000132	0.00014	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—INS—metabolic syndrome X	0.000131	0.000139	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTGS2—metabolic syndrome X	0.000129	0.000137	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NOS3—metabolic syndrome X	0.000126	0.000133	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALB—metabolic syndrome X	0.00012	0.000127	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTGS2—metabolic syndrome X	0.000116	0.000122	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NOS3—metabolic syndrome X	0.000115	0.000122	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTGS2—metabolic syndrome X	0.000105	0.000111	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—AKT1—metabolic syndrome X	6.51e-05	6.87e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—AKT1—metabolic syndrome X	5.81e-05	6.13e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—AKT1—metabolic syndrome X	5.29e-05	5.59e-05	CbGpPWpGaD
